TY  - CONF

T1  - Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion

JO  - Value in Health

UR  - http://eprints.whiterose.ac.uk/111902/

PY  - 2016/10/31

AU  - Goodall M

AU  - Tosh J

AU  - Alshreef A

AU  - Tappenden P

ED  - 

DO  - DOI: 10.1016/j.jval.2016.09.116

PB  - Elsevier BV

VL  - 19

IS  - 7

SP  - A366

EP  - A366

Y2  - 2024/12/21

ER  -